2D Healthcare
2D Healthcare
I-Cell Networks · Japan
Какое лечение при какой опухоли?
Гид по диагнозу

Lymphoma

In lymphoma, chemotherapy and immunotherapy are strong standards; for refractory/relapsed B-cell lymphomas, CAR-T cell therapy is a licensed and established option in Japan.

Что важно знать об этом диагнозе

  • CAR-T is a cell therapy with demonstrated efficacy in relapsed B-cell lymphoma.

  • iPSC-derived 'off-the-shelf' cell programs (iCART) are an investigational approach aiming to shorten waiting time.

  • Evaluation is based on lymphoma subtype and prior treatment responses.

Важно

Lymphoma subtypes behave very differently; your file is reviewed by the hematology expert board.